B. Riley Financial’s DNA X Inc SONM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,800
Closed -$5.85M 46
2021
Q2
$5.85M Hold
5,800
0.77% 16
2021
Q1
$8.56M Sell
5,800
-766
-12% -$1.35M 0.95% 13
2020
Q4
$8.56M Hold
6,566
1.39% 11
2020
Q3
$9.17M Hold
6,566
2.41% 10
2020
Q2
$9.47M Buy
6,566
+5,337
+434% +$8.52M 3.43% 7
2020
Q1
$1.55M Hold
1,229
1.06% 16
2019
Q4
$8.03M Hold
1,229
2.02% 8
2019
Q3
$6.48M Hold
1,229
2.4% 9
2019
Q2
$28.2M Buy
+1,229
New +$31.2M 13.54% 3

Other funds holding SONM

B. Riley Financial's SONM Position: Q3 2021 in Review

B. Riley Financial sold out of DNA X Inc (SONM) in Q3 2021, closing a stake of 5,800 shares — an estimated $5.85M sold.

B. Riley Financial first reported a position in SONM in Q2 2019 and held it in 9 quarters. The position peaked at $28.2M in Q2 2019. 11 funds tracked by Wall St. Rank hold SONM as of Q3 2021.

  • B. Riley Financial reported no remaining DNA X Inc position as of Q3 2021 after selling out during the quarter.
  • B. Riley Financial sold 5,800 DNA X Inc shares in Q3 2021, an estimated $5.85M.
  • B. Riley Financial first reported a position in DNA X Inc in Q2 2019 and held it in 9 quarters.
  • B. Riley Financial's DNA X Inc position peaked at $28.2M in Q2 2019.
  • 11 funds tracked by Wall St. Rank held DNA X Inc as of Q3 2021.

Based on B. Riley Financial's 13F filing for Q3 2021, filed 10 Nov 2021.